Outset Medical, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Outset Medical, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $77.00K, a 92.62% decline year-over-year.
- Outset Medical, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $6.00K, a 99.12% decline year-over-year.
- Outset Medical, Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-09-30 was $1.19M, a 123.77% increase year-over-year.
- Outset Medical, Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $1.04M, a 0.10% increase year-over-year.
- Outset Medical, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $83.00K, a 97.15% decline from fiscal 2023.
- Outset Medical, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $2.92M, a 24.04% decline from fiscal 2022.
- Outset Medical, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $3.84M, a 49.66% decline from fiscal 2021.
- Outset Medical, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $7.63M, a 538.33% increase from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-12-31 | $83.00K 10-K · filed 2026-02-13 | |
| 2024-06-30 | $77.00K 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $6.00K 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $2.92M 10-K · filed 2026-02-13 | |
| 2023-09-30 | $1.19M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $1.04M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $684.00K 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $3.84M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $530.00K 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $1.04M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $1.66M 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $7.63M 10-K · filed 2024-02-21 | |
| 2021-09-30 | $4.59M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $1.72M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $380.00K 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $1.20M 10-K · filed 2023-02-13 | |
| 2020-09-30 | $1.05M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $80.00K 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $14.00K 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $364.00K 10-K · filed 2022-02-23 | |
| 2019-09-30 | $16.00K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $162.00K 10-Q · filed 2020-11-12 | |
| 2019-03-31 | $76.00K 10-Q · filed 2020-11-12 | |
| 2018-12-31 | $315.00K 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |